Sato Foods Industries Co., Ltd. (TYO:2814)

Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	9,474	8,660	7,796	10,616	9,181	10,094
Market Cap Growth	11.08%	11.08%	-26.56%	15.63%	-9.04%	3.46%
Enterprise Value	422	-387	-1,135	2,088	908	2,496
Last Close Price	2549.00	2330.00	1959.11	1628.18	1381.64	1484.58
PE Ratio	16.42	14.53	10.09	27.65	12.63	34.57
PS Ratio	1.49	1.36	1.28	1.81	1.63	1.66
PB Ratio	0.49	0.45	0.40	0.56	0.49	0.55
P/TBV Ratio	0.49	0.45	0.40	0.56	0.49	0.55
P/FCF Ratio	14.29	13.06	7.21	51.79	14.17	8.95
P/OCF Ratio	10.29	9.40	6.69	19.20	10.88	7.83
EV/Sales Ratio	0.07	-	-	0.36	0.16	0.41
EV/EBITDA Ratio	0.45	-	-	2.30	0.86	2.26
EV/EBIT Ratio	0.63	-	-	3.38	1.16	3.58
EV/FCF Ratio	0.64	-	-	10.19	1.40	2.21
Debt / Equity Ratio	0.04	0.04	0.03	0.04	0.04	0.04
Debt / EBITDA Ratio	0.71	0.71	0.71	0.74	0.64	0.61
Debt / FCF Ratio	1.01	1.01	0.62	3.27	1.03	0.59
Asset Turnover	0.30	0.30	0.29	0.29	0.28	0.31
Inventory Turnover	3.07	3.07	3.08	3.00	2.89	3.59
Quick Ratio	7.12	7.12	6.16	7.41	6.92	6.28
Current Ratio	8.21	8.21	6.97	8.53	7.89	7.14
Return on Equity (ROE)	3.05%	3.05%	3.99%	2.03%	3.92%	1.62%
Return on Assets (ROA)	1.96%	1.96%	1.96%	1.89%	2.42%	2.22%
Return on Capital (ROIC)	2.08%	2.08%	2.07%	1.98%	2.54%	2.33%
Return on Capital Employed (ROCE)	3.40%	3.40%	3.30%	3.20%	4.20%	3.80%
Earnings Yield	6.29%	6.88%	9.92%	3.62%	7.92%	2.89%
FCF Yield	7.00%	7.66%	13.87%	1.93%	7.06%	11.18%
Payout Ratio	28.52%	28.52%	20.70%	38.28%	25.72%	64.04%
Buyback Yield / Dilution	6.00%	6.00%	2.63%	32.70%	0.87%	0.03%

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.